Understanding OUR Cytokine-Based Immunotherapy Candidates Our dedication extends to advancing a robust portfolio of programs aimed toward increasing the horizons of cytokine-based immunotherapy, specifically for cancers where treatment choices remain limited. Use the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Discover Our Pipeline We https://financefeeds.com/usdc-market-cap-climbs-past-56b-narrowing-gap-with-tether/